Solve Therapeutics has raised $120 million to accelerate the development of its clinical pipeline and proprietary CloakLink linker platform.

Andelyn Biosciences has entered a non-exclusive worldwide license and collaboration agreement with Solid Biosciences Inc. for ...

Merus N.V. and Halozyme Therapeutics Inc. have entered into a global non-exclusive collaboration and license agreement.

AdvanCell Pty Ltd, a clinical-stage radiopharmaceutical company, has appointed Philina Lee, PhD as CEO and member of the ...

Tyruko (natalizumab) is the first and only biosimilar for Multiple Sclerosis. Polpharma Biologics, a biopharmaceutical company group focused on biosimilars development and manufacturing, confirmed ...

Sonoma Biotherapeutics Inc. has appointed Stephen Dilly, former President and CEO of Codexis Inc., and current Chair of the ...

Ono Pharmaceutical Co. Ltd. has opened a new 733-square-meter office in Zug, Switzerland to accommodate the company’s growth ...

Vice President of Business Development shares insight on industry trends and bringing drugs to market faster.

Q Earnings: $5.8 billion (+83%) YTD Revenues: $48.6 billion (flat) YTD Earnings: $15.3 (+14%) Comments: KEYTRUDA sales were ...

Global biopharmaceutical sales were $16.3 billion, down 6%. Primary Care sales were down 16% to $7.6 billion. Eliquis sales ...

3Q Earnings: $186 million (earnings were $1.6B 3Q24) YTD Revenues: $44.5 billion (+8%) YTD Earnings: $2.4 billion (-44%) ...

TandemAI has secured a $22 million Series A extension to further develop its drug discovery platform, which combines advanced ...